ALDH3A2 and cancer: These results along with the observations from cancer cell lines propose a model wherein increased expression of ALDH3A2 is associated with relative decreases in oxidative phosphorylation - a prominent feature from the analysis of post-mortem AD brains - and that this may contribute to the loss of glutamatergic neurons in disease.